How might age-based universal screening change lung cancer detection and mortality rates (Medscape AI) +... ++++++ ++ +++

https://www.medscape.com/ai-search?query=How%20might%20age-based%20universal%20screening%20change%20lung%20cancer%20detection%20and%20mortality%20rates&ecd=mkm_ret_251214_mscpmrk_onc_lung-cancer_etid7952470&uac=148436CN&impID=7952470 Age-based universal lung cancer screening models project substantial increases in early detection and reductions in mortality compared with current risk-based approaches. Latest Stories Lung Cancer Deaths: How to Potentially Prevent Thousands https://www.medscape.com/viewarticle/expanded-lung-cancer-screening-could-avert-many-more-deaths-2025a1000wxo?ecd=mkm_ret_251214_mscpmrk_onc_lung-cancer_etid7952470&uac=148436CN&impID=7952470 Do ICIs Have Long-Term Survival Benefit? https://www.medscape.com/viewarticle/do-icis-have-long-term-survival-benefit-2025a1000y48?ecd=mkm_ret_251214_mscpmrk_onc_lung-cancer_etid7952470&uac=148436CN&impID=7952470 Unexpected Lung-Brain Cancer Link Revealed https://www.medscape.com/viewarticle/devious-lung-brain-cancer-connection-surprises-researchers-2025a1000wxa?ecd=mkm_ret_251214_mscpmrk_onc_lung-cancer_etid7952470&uac=148436CN&impID=7952470 ICIs Beyond Progression: Is It Worth It? https://reference.medscape.com/viewarticle/immunotherapy-after-progression-advanced-lung-cancer-nsclc-2025a1000njw?ecd=mkm_ret_251214_mscpmrk_onc_lung-cancer_etid7952470&uac=148436CN&impID=7952470 Neoadjuvant Nivolumab Shows Lasting Gains https://www.medscape.com/viewarticle/neoadjuvant-nivolumab-nsclc-follow-study-confirms-lasting-2025a1000uon?ecd=mkm_ret_251214_mscpmrk_onc_lung-cancer_etid7952470&uac=148436CN&impID=7952470 SBRT vs Standard RT: Which Offers a QoL Edge in NSCLC? https://www.medscape.com/viewarticle/sbrt-vs-standard-rt-which-offers-qol-edge-nsclc-2025a1000y62?ecd=mkm_ret_251214_mscpmrk_onc_lung-cancer_etid7952470&uac=148436CN&impID=7952470 Case-by-Case When NSCLC Decisions Can’t Wait for NGS https://www.medscape.com/viewarticle/trusting-instinct-when-nsclc-decisions-cant-wait-ngs-2025a1000v64?ecd=mkm_ret_251214_mscpmrk_onc_lung-cancer_etid7952470&uac=148436CN&impID=7952470 Nodal Clues Shift NSCLC Treatment Path https://www.medscape.com/viewarticle/stage-iib-or-iiia-critical-role-nodal-evaluation-nsclc-2025a1000kt9?ecd=mkm_ret_251214_mscpmrk_onc_lung-cancer_etid7952470&uac=148436CN&impID=7952470 US Drug Spotlight Durvalumab https://reference.medscape.com/drug/imfinzi-durvalumab-1000145?ecd=mkm_ret_251214_mscpmrk_onc_lung-cancer_etid7952470&uac=148436CN&impID=7952470 Cemiplimab https://reference.medscape.com/drug/libtayo-cemiplimab-1000263?ecd=mkm_ret_251214_mscpmrk_onc_lung-cancer_etid7952470&uac=148436CN&impID=7952470 Trastuzumab Deruxtecan https://reference.medscape.com/drug/enhertu-trastuzumab-deruxtecan-4000032?ecd=mkm_ret_251214_mscpmrk_onc_lung-cancer_etid7952470&uac=148436CN&impID=7952470